top of page

Search Results

Search results for "class A GPCR"

Results found for "class A GPCR"

  • Integrated GPCR Drug Discovery: A Structured Framework for Modern Programs

    GPCR University Masterclass — Integrated GPCR Discovery in Practice Dr. GPCR Masterclass ➤ Eurofins DiscoverX Partnership — Tools and Insight for GPCR Drug Discovery Modern GPCR discovery depends on more than hypotheses. GPCR Premium Membership Gives You an Edge GPCR drug discovery is accelerating — across obesity, CNS, GPCR operates as a membership-based, nonprofit initiative — built to strengthen the GPCR field through

  • Allosteric Binding Demystified: Smarter GPCR Drug Discovery

    Hello GPCR Enthusiasts, Interpreting binding data isn’t optional—it’s career-defining. GPCR Premium: Sneak Peek Every week, Premium Members get curated intelligence they won’t find in open Read the article now ➤ Discovery on Target - The Next Wave of GPCR Drug Discovery The 20th Annual GPCR-Based GPCR Premium Membership Gives You an Edge The GPCR field is advancing at breakneck speed. The pace of GPCR innovation is accelerating.

  • Better GPCR Drug Discovery Decisions Start With Structured Learning

    If you work in GPCR research, clarity is leverage. Upcoming events: 12th Adhesion GPCR Workshop; GPCRnet International Symposium; 5th GPCRs Targeted Drug GPCR University has undergone a structural redesign. GPCR Premium Membership Gives You an Edge GPCR science is accelerating across obesity, CNS, oncology, GPCR University courses — now included in Premium.

  • Enzyme Inhibition Pharmacology: The Hidden Gatekeepers of GPCR Drug Discovery

    Before your GPCR ligand ever meets its receptor, it meets the enzymes that determine whether it survives Discovery Program So what does that mean for discovery scientists designing the next generation of GPCR Even the most elegant GPCR ligand can fail if it never reaches its receptor. GPCR members save 50%+  with your Weekly News code. 👉 Join Terry’s Corner & Secure Your Spot for the Kenakin with your own enzyme or GPCR interaction puzzles.

  • How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

    partnership built on trust and curiosity — reshaped both careers and helped unlock a new generation of GPCR How a Collaboration Led to a GPCR Imaging Breakthrough JB didn’t set out to contribute to a GPCR imaging It was the start of a scientific partnership with the potential to shift how GPCRs could be visualized How Chemical Probes Transformed GPCR Imaging and Outperformed Antibodies As JB continued exploring the Designing Reliable GPCR Imaging Tools for Real Biological Systems Success brought new challenges.

  • How System-Level GPCR Thinking Prevents Discovery Failures

    Upcoming events:  Adhesion GPCR Workshop; GRC—Transporters, Ion Channels & GPCRs; MPGPCR Joint Satellite GPCR Podcast: Chemical Probes for GPCR Imaging with Dr. GPCR Premium Membership Gives You an Edge Premium gives GPCR scientists and biotech teams a single, trusted GPCR and the offered resources in my work sphere." GPCR research and education across the global community.

  • Why Intracellular Drugs May Hold the Key to GPCR Therapeutics

    of how residence time—not potency—predicts therapeutic coverage ✅ Insight into cryptic intracellular GPCR evaluating scaffold permeability using modern, cost-effective pharmacokinetic assays   Why Intracellular GPCR Drugs Change the Game For decades, drug design has treated GPCRs as surface targets. shows how this plays out in model systems and clinical data—and why residence time should be a first-class GPCRs now have validated intracellular  allosteric sites.

  • How a Failed Experiment Created a Powerful GPCR Imaging Tool

    Broichhagen aka JB, the goal was bold and elegant: Create a photo-switchable ligand to remotely control GPCR They had a tool that did bind the GPCR… but not in the light-controlled way they wanted. The Moment a Failed Tool Became a GPCR Imaging Breakthrough What the compound did reliably do was label This solved a long-standing problem in GPCR biology: You can't understand signaling if you can’t see  The Larger Lesson for Scientists and Innovators This story isn’t just about a GPCR imaging tool.

  • From Farm Fields to GPCR Discovery, GLP-1 and GIP

    Following the Data Into GPCR, Metabolic Disease and GLP-1 After his PhD, Hodson entered neuroendocrinology GPCRs Re-Enter the Story — Not as Theory, but as Tools GPCRs have always been powerful drug targets — That partnership eventually produced fluorescent GPCR tools  that allow researchers to visualize GPCR Emerging direction: Multi-target GPCR + myostatin-pathway combinations. Can GPCRs act as “delivery ZIP codes” for targeted therapies?

  • How Schild Analysis Protects Your Conclusions in GPCR Research

    Listen to the episode ➤ Quick Links Assess GPCR Biased Signaling of Agonist How GPCR Collaboration Built an Innovation Engine From Pipettes to Platforms: The Evolution of GPCR Research How GPCR Spatial Signaling GPCR Premium Membership Gives You an Edge Premium delivers a clear, noise-free stream of GPCR intelligence GPCR innovation is accelerating. GPCR Team

  • Therapeutic validation of an orphan G protein‐coupled receptor

    Historically, ligands for GPCRs have been identified before their receptor counterparts. Orphan GPCRs have been shown to play key roles in various physiological functions, such as sensory perception Therefore, matching a ligand to an orphan GPCRs, the process of de-orphanizing, is of great importance GPR84 is a Gi‐coupled class A GPCR mainly expressed in immune cells and microglia in the brain (Wojciechowicz #GPCR #DrGPCR#Ecosystem

  • A Note from Yamina: Building the Next Chapter of Dr. GPCR

    GPCR. Dear Dr. GPCR, it was with a simple goal: to connect people who shared a passion for GPCR science and discovery GPCR Foundry  — our R&D and biotech hub designed to bridge GPCR science with execution. The Dr. GPCR resources, connect new scientists, and earn rewards  for helping expand access to GPCR knowledge GPCR About Dr. GPCR Dr.

  • Predicting GPCR Function: Inside the Carlsson Lab’s Modeling Toolbox

    For decades, GPCRs have been the cornerstone of pharmacology. GPCR Modeling in Context: Then and Now When Carlsson entered the GPCR field in the early 2000s, structural Why Predictive GPCR Modeling Matters Now The convergence of machine learning, improved GPCR structures Want to go deeper into GPCR modeling? Dr. GPCR Podcast Push the boundaries of what's possible 👉 Join the Dr.

  • Ben Clements on Rescuing Opioids with GPCR Modulators

    His work highlights how foundational GPCR science can drive therapeutic innovation. The GPCR Angle Ben sees GPCRs as untapped goldmines for drug discovery. Ready to dive deeper into GPCR drug discovery? Want to push the boundaries of GPCR drug discovery? Start learning with our GPCR University today. _______________ Keyword Cloud: GPCR research community , GPCR drug discovery, mu-opioid receptor, positive allosteric modulators, GPCR training program, GPCR

  • How Breakthroughs Happen: Eric Trinquet on Innovation, Serendipity & GPCRs

    Eric Trinquet, a veteran innovator behind functional GPCR assays like HTRF and IP-One, believes rigid If you’re building tools or careers in GPCR science, this is your playbook. It began with an unmet need: how to track Gq-coupled GPCR activity without the mess of calcium flux or GPCR   Dr. GPCR X Revvity Collaboration ⸻ Want more like this? 👉 Join the Dr. GPCR Premium Ecosystem  for behind-the-scenes access to GPCR innovators, exclusive deep-dives, and practical

  • From Switches to Microcircuits: GPCR Biased Signaling and the Future of Drug Discovery

    Why GPCR Drug Discovery Is More Complex Than It Looks G protein-coupled receptors (GPCRs) have long occupied Allosteric Modulation and the Microcircuit Model of GPCR Pharmacology Understanding GPCRs as allosteric Emerging Families and Orphan GPCRs: Expanding the Drug Discovery Target Space Family A and B GPCRs — But the GPCR superfamily is considerably broader. Related Resources eBook: Insights into GPCR Drug Discovery and Development: Exploring GPCR-Ligand Interactions

  • Why Kinetics Matter More Than Kd in GPCR Drug Discovery

    Welcome GPCR Fans,   Every discovery-phase decision you make shapes your entire pipeline trajectory—and Upcoming events:  5th MMCS New Trends in Drug Discovery; GPCR-UK Network Meeting; neuroGPCR Symposium Must-read publications:  GPCRchimeraDB: Database of engineered GPCR designs. GPCR University Course Attendee Dr. The pace of GPCR innovation is accelerating.

  • Dr. GPCR Spotlights Revvity’s pHSense™ Internalization Tools

    GPCR , the global nonprofit platform dedicated to advancing GPCR science through education, community GPCR Ecosystem. GPCR Podcast To mark the spotlight, Dr. GPCR  invited Dr. Eric Trinquet  to the Dr. GPCR. GPCR Dr.

  • The Boston Happy Hour: What Happens When GPCR Scientists Enter the Cafe

    The GPCR Happy Hour Room What struck me first was the range. GPCR Happy Hour is free to every scientist who walks in. GPCR YouTube channel, and I encourage you to watch it. GPCR: welcome. This is what we do. Come find us in the fall. the people https://www.ecosystem.drgpcr.com/gpcr-university

  • First AMA of 2026: GPCR Pharmacology, Biased Signaling & Mechanistic Clarity

    2026 GPCR Pharmacology AMA: Receptor Theory, Biased Signaling & Assay Interpretation The first GPCR Pharmacology as new videos are released: ▶️ https://www.youtube.com/@TerryPharmacologyCorner New White Paper on GPCR School of Medicine, has authored a new white paper in collaboration with Eurofins DiscoverX: Assess GPCR ) Systematic comparison of biased agonists using modern functional assays For scientists working in GPCR Forty years of pharmacological expertise — organized into a year-round framework for serious GPCR scientists

  • Inside the New Dr. GPCR Ecosystem: Learning, Insight, and Momentum for 2026

    Must-read publications:  GPCRs in neurological disorders; OSTα-OSTβ structure; GPCR–G protein–β-arrestin GPCR Podcast—GPCR Assay Strategy, Bias, and Translational Drug Discovery In this episode of the Dr. GPCR podcast , Dr. GPCR innovation is accelerating. GPCR Team

  • Is Your GPCR Drug Discovery Program Built for Breakthroughs or Breakdowns?

    In the high-stakes world of GPCR drug discovery , breakthrough science isn't enough. GPCR, we recognized this core problem. This is the essence of de-risking GPCR programs through operational excellence. the entire GPCR program as a single, interconnected entity. The GPCR Precision Blueprint is more than a concept.

  • Decoding Olfactory GPCRs: How AlphaFold and AI Are Changing the Game

    we explore how computational tools—especially AlphaFold —are helping crack the mystery of olfactory GPCRs The Problem: Hundreds of Receptors, Almost No Ligands Alessandro’s work focuses on olfactory GPCRs—nearly : Predicting the “Face” of a Receptor When Alessandro began his PhD, structural models of olfactory GPCRs —Alessandro Nicoli A New Era of GPCR Research AlphaFold didn’t just fill a gap—it shifted the focus of Start with our GPCR training program and get hands-on with virtual tools shaping the future of drug discovery

  • Pharmacology at Your Fingertips: Terry’s Corner Launches

    Yamina’s Corner delivers GPCR consulting that cuts through the noise, designing assay cascades, setting GPCR partner Celtarys Research has validated a TR-FRET assay for cannabinoid receptor ligands using their Read The Full Article GPCR Publication Highlights   Chemokine–GPCR Selectivity Unveiled Sequence- and Distinct Ligand Activation in NMBR Simulations show how two ligands differently activate class A GPCR GPCR Team Join Our Newsletter!

  • When the Islet Lit Up: Advancing GPCR Imaging in Native Tissue

    A single successful GPCR imaging experiment can transform a project’s trajectory. Interdisciplinary design isn’t optional in GPCR imaging. It’s the catalyst. And the most striking validation came from in vivo GPCR imaging. Strong GPCR imaging tools come from strong interdisciplinary relationships.  🎧 Listen to the full episode https://www.ecosystem.drgpcr.com/dr-gpcr-podcast/chemical-probes-for-gpcr-imaging-and-internalization

  • Ode to GPCRs

    11] Through Nobel prize-winning research work, Wald made important discoveries on the role that the class-A archetypical GPCR rhodopsin plays in scoptic vision and night blindness. 2004 Nobel Prize in Physiology or Medicine went to Richard Axel and Linda Brown Buck for their work on Class-A These odorant receptors (ORs) now account for about 60% of all identified human GPCRs. GPCR signaling, and location bias.[68–70] Further, our understanding of cross-talk between GPCR-mediated

  • Accelerating GPCR Drug Discovery: What 40 Years of Pharmacology Reveal

    Why Speed Matters in GPCR Drug Discovery Nine out of ten GPCR programs stall  not because the target In accelerating GPCR drug discovery, the bottleneck isn’t target identification — it’s turning validated GPCR Kinetics: The Critical Data You Can’t Afford to Skip Equilibrium potency data only tells part of “GPCRs are nature’s prototype allosteric proteins. Everything they do is allosteric.” Kenakin with your own enzyme or GPCR interaction puzzles.

  • Assay Volume Control: Your GPCR Drug Discovery Power Lever

    Enhance your GPCR research with deeper assay insights for more effective results. This Week’s GPCR Intelligence: If you want cleaner decisions, start with the system—then the ligand. Breakthroughs this week: C. elegans avoids EGCG via SRXA-7 GPCR; a bidirectional GPCR switch modulates allosteric site on an orphan GPCR. 🔍 This Week in Dr. GPCR innovation is accelerating.

  • Odorant receptors – a bit of smell for drug discovery

    function and expression landscape Odorant receptors (ORs) belong to the G protein-coupled receptor (GPCR OR51E1 and OR51E2, initially assumed to be GPCRs only expressed in prostate tissue, play a role in prostate of GPCRs. expression of ORs is generally more technically challenging compared with expression of nonolfactory GPCRs Check the original article at https://pubmed.ncbi.nlm.nih.gov/35999088/ #GPCR #DrGPCR#Ecosystem

  • GPCR Pharmacology Insights That Prevent Real Drug Discovery Failures

    Kenakin  highlighted a fundamental truth: GPCR systems do not offer stable, proportional input–output Teams equipped with deep GPCR pharmacology insights make different decisions. The sections below synthesize the key topics addressed during the AMA and highlight the GPCR pharmacology This is a core GPCR pharmacology insight:ligand → receptor → G protein is never the entire story. GPCR innovation is accelerating, and those who invest in deeper GPCR pharmacology insights today will

bottom of page